Urinary iron excretion in young thalassemic patients receiving combined chelation treatment with deferoxamine and deferiprone.

Abstract

To assess and compare the individual effect of different chelation agents on urinary iron excretion (UIE), we asked every patient, receiving combined chelation treatment with deferiprone (DFP) and deferoxamine (DFO), to provide four 24-hours urine samples; 2 samples were collected during days when patient was receiving only DFP, whereas the other 2 were… (More)

Topics

Cite this paper

@article{Christoforidis2007UrinaryIE, title={Urinary iron excretion in young thalassemic patients receiving combined chelation treatment with deferoxamine and deferiprone.}, author={Athanasios Christoforidis and Eleni Zevgaridou and Ioanna Tsatra and Vassilios Perifanis and Efthymia Vlachaki and Ioannis Papassotiriou and Filia Apostolakou and Miranda Athanassiou-Metaxa}, journal={Journal of pediatric hematology/oncology}, year={2007}, volume={29 9}, pages={598-601} }